49.51
price up icon3.02%   1.45
after-market Handel nachbörslich: 49.91 0.40 +0.81%
loading
Schlusskurs vom Vortag:
$48.06
Offen:
$48
24-Stunden-Volumen:
1.67M
Relative Volume:
1.18
Marktkapitalisierung:
$10.28B
Einnahmen:
$1.98B
Nettoeinkommen (Verlust:
$83.59M
KGV:
132.38
EPS:
0.374
Netto-Cashflow:
$502.31M
1W Leistung:
+4.34%
1M Leistung:
+5.88%
6M Leistung:
+1.87%
1J Leistung:
+13.69%
1-Tages-Spanne:
Value
$47.99
$49.64
1-Wochen-Bereich:
Value
$47.66
$49.64
52-Wochen-Spanne:
Value
$37.74
$49.64

Qiagen Nv Stock (QGEN) Company Profile

Name
Firmenname
Qiagen Nv
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
5,700
Name
Twitter
@QIAGEN
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
QGEN's Discussions on Twitter

Vergleichen Sie QGEN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
QGEN
Qiagen Nv
49.51 10.28B 1.98B 83.59M 502.31M 0.374
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
427.62 157.79B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.91 138.02B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
532.00 42.36B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
116.19 32.08B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
187.38 27.28B 15.50B 1.33B 2.16B 7.34

Qiagen Nv Stock (QGEN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-24 Eingeleitet Barclays Overweight
2025-04-04 Herabstufung Redburn Atlantic Buy → Neutral
2025-02-19 Herabstufung Robert W. Baird Outperform → Neutral
2025-01-06 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-12-10 Hochstufung Jefferies Hold → Buy
2024-10-17 Herabstufung HSBC Securities Buy → Hold
2024-06-27 Hochstufung Wolfe Research Peer Perform → Outperform
2023-12-19 Eingeleitet Wells Fargo Equal Weight
2023-12-13 Eingeleitet Wolfe Research Peer Perform
2023-12-07 Hochstufung Goldman Neutral → Buy
2023-09-12 Eingeleitet Robert W. Baird Outperform
2023-05-23 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-10-18 Eingeleitet Morgan Stanley Equal-Weight
2022-01-18 Hochstufung DZ Bank Hold → Buy
2021-10-15 Fortgesetzt Cowen Market Perform
2021-10-14 Eingeleitet Redburn Buy
2021-07-14 Herabstufung Kepler Buy → Hold
2021-06-03 Eingeleitet Goldman Neutral
2020-10-06 Fortgesetzt BofA Securities Buy
2020-09-28 Hochstufung Kepler Hold → Buy
2020-08-24 Hochstufung Citigroup Neutral → Buy
2020-08-20 Fortgesetzt JP Morgan Overweight
2020-08-17 Hochstufung Berenberg Hold → Buy
2020-08-14 Hochstufung Deutsche Bank Hold → Buy
2020-08-14 Hochstufung Exane BNP Paribas Neutral → Outperform
2020-03-04 Herabstufung Berenberg Buy → Hold
2020-01-08 Eingeleitet Wells Fargo Equal Weight
2020-01-07 Eingeleitet Citigroup Neutral
2019-12-26 Fortgesetzt BofA/Merrill Underperform
2019-11-15 Eingeleitet Stifel Hold
2019-11-14 Hochstufung Evercore ISI In-line → Outperform
2019-11-14 Hochstufung JP Morgan Underweight → Overweight
2019-11-14 Hochstufung Kepler Reduce → Hold
2019-10-17 Hochstufung Wolfe Research Peer Perform → Outperform
2019-10-09 Herabstufung Kepler Hold → Reduce
2019-10-08 Herabstufung Barclays Overweight → Equal Weight
2019-10-08 Herabstufung Deutsche Bank Buy → Hold
2019-10-08 Herabstufung JP Morgan Neutral → Underweight
Alle ansehen

Qiagen Nv Aktie (QGEN) Neueste Nachrichten

pulisher
Jul 22, 2025

BlackRock’s Significant Stake in Qiagen Disclosed by AFM - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Qiagen Announces Voting Rights Notification Involving BlackRock - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

QIAGEN launches long read sequencing panels for complex genomic analysis - StreetInsider

Jul 22, 2025
pulisher
Jul 22, 2025

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels - Business Wire

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Qiagen N.V. stock priceRapid wealth multiplication - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Qiagen N.V. Stock Analysis and ForecastJaw-dropping returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Qiagen NV stock reaches 52-week high at 48.91 USD - Investing.com India

Jul 22, 2025
pulisher
Jul 22, 2025

Is Qiagen N.V. a good long term investmentExceptional return forecasts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Qiagen N.V. stockMassive wealth growth - Autocar Professional

Jul 22, 2025
pulisher
Jul 18, 2025

Qiagen Announces Significant Voting Rights Notification by BlackRock - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche - Yahoo Finance

Jul 18, 2025
pulisher
Jul 15, 2025

Qiagen N.V. (NYSE:QGEN) is favoured by institutional owners who hold 79% of the company - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN

Jul 15, 2025
pulisher
Jul 11, 2025

Qiagen and Gencurix partner for oncology tests - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Qiagen NV stock hits 52-week high at 48.82 USD By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

QIAGEN Announces Managerial Share Transaction - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

Qiagen NV stock hits 52-week high at 48.82 USD - Investing.com Australia

Jul 11, 2025
pulisher
Jul 08, 2025

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast - Business Wire

Jul 08, 2025
pulisher
Jul 08, 2025

QIAGEN NV : Deutsche Bank maintains a Buy rating - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

QIAGEN Sets August 5 for Q2 2025 Earnings: Global Investors Briefing Across 3 Time Zones - Stock Titan

Jul 08, 2025
pulisher
Jul 03, 2025

Baptista Research Begins Qiagen Coverage at Hold - MarketScreener

Jul 03, 2025
pulisher
Jul 03, 2025

Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays - MSN

Jul 03, 2025
pulisher
Jul 02, 2025

Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2031 - MarketScreener

Jul 02, 2025
pulisher
Jul 02, 2025

Qiagen N : announces adjustment of conversion price under its US$500,000,000 Convertible Bonds due 2027 - MarketScreener

Jul 02, 2025
pulisher
Jun 30, 2025

Qiagen N.V.(NYSE: QGEN) dropped from Russell 1000 Dynamic Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Ex-Dividend Reminder: Comcast, Qiagen and HA Sustainable Infrastructure Capital - Nasdaq

Jun 30, 2025
pulisher
Jun 28, 2025

Qiagen Announces Managerial Share Transaction - TipRanks

Jun 28, 2025
pulisher
Jun 27, 2025

Qiagen N.V. (QGEN) Expands MRD Testing with Tracer and Foresight Partnerships - MSN

Jun 27, 2025
pulisher
Jun 27, 2025

QIAGEN Announces Election of Stephen Rusckowski as Chairman of S - GuruFocus

Jun 27, 2025
pulisher
Jun 26, 2025

Qiagen (QGEN) Target Price Raised by B of A Securities | QGEN Stock News - GuruFocus

Jun 26, 2025
pulisher
Jun 26, 2025

Qiagen stock reaches 52-week high at 48.24 USD - Investing.com

Jun 26, 2025
pulisher
Jun 24, 2025

Barclays Starts Qiagen NV (QGEN) at Overweight - StreetInsider

Jun 24, 2025
pulisher
Jun 24, 2025

Here's Why Qiagen (QGEN) is a Strong Value Stock - Nasdaq

Jun 24, 2025
pulisher
Jun 23, 2025

Qiagen Announces BlackRock’s Significant Voting Rights Disclosure - TipRanks

Jun 23, 2025
pulisher
Jun 23, 2025

Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo.co

Jun 23, 2025
pulisher
Jun 21, 2025

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions - MSN

Jun 21, 2025
pulisher
Jun 19, 2025

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership - BioSpace

Jun 19, 2025
pulisher
Jun 18, 2025

Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Qiagen’s Voting Rights Notification Highlights BlackRock’s Influence - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

BlackRock’s Significant Stake in Qiagen Revealed - TipRanks

Jun 18, 2025

Finanzdaten der Qiagen Nv-Aktie (QGEN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research WAT
$287.46
price up icon 2.06%
$139.92
price down icon 0.50%
diagnostics_research DGX
$178.24
price up icon 7.08%
diagnostics_research LH
$252.07
price up icon 3.72%
diagnostics_research MTD
$1,218.96
price up icon 4.50%
diagnostics_research IQV
$187.38
price up icon 17.88%
Kapitalisierung:     |  Volumen (24h):